Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. The findings, published in The ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

Please provide your email address to receive an email when new articles are posted on . A 50% or greater reduction in exacerbation rate was one of the four criteria for response. Criteria also ...

Advice on recommended inhaler treatment regimens for asthma, and the shift to SABA-free care, and how to embed these regimens in practice ...

A new study published in Respiratory Medicine offers hope for a long-term treatment of asthma by directly targeting the structural changes that occur in the airway and lungs. Unlike current drugs that ...

Mauli Desai, MD, Allergist & Immunologist, and David Rosenstreich, MD, Professor of Allergy & Immunology, Microbiology & Immunology, and Otorhinolaryngology, for Montefiore Einstein Anyone who’s ever ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients who received biologic treatment for asthma did ...

The new asthma treatment that could ‘transform lives’ - The injection is recommended as an additional maintenance treatment for patients over 12 when usual medications have not proven effective enough ...

A possible way to tackle one of the underlying causes of asthma has been developed. In tests in mice, the researchers were able to virtually eliminate asthmatic symptoms within two weeks and return ...